Austar Lifesciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	227.39	166.81	163.77	133.62	198.45
Short-Term Investments	-	1	10	14.51	21.29
Cash & Short-Term Investments	227.39	167.81	173.77	148.13	219.74
Cash Growth	35.51%	-3.43%	17.31%	-32.59%	23.37%
Accounts Receivable	979.83	987.01	994.69	1,000	672.83
Other Receivables	-	31.31	26.13	20.01	27.59
Receivables	979.83	1,018	1,021	1,020	700.42
Inventory	279.65	238.43	243.16	388.11	423.26
Other Current Assets	126.84	127.21	136.08	244.35	319.82
Total Current Assets	1,614	1,552	1,574	1,801	1,663
Property, Plant & Equipment	392.82	414.13	443.85	433.61	311.81
Long-Term Investments	66.59	60.28	82.11	85.5	39.7
Other Intangible Assets	40.39	42.3	42.47	55.87	21.11
Long-Term Deferred Tax Assets	12.38	15.17	16.72	12.78	8.92
Other Long-Term Assets	2.11	-	-	-	-
Total Assets	2,128	2,084	2,159	2,389	2,045
Accounts Payable	460.35	382.11	405.93	426.2	352.35
Accrued Expenses	87.48	111.27	114.22	180.93	155.36
Short-Term Debt	237.62	229.75	255.31	173.55	56.09
Current Portion of Long-Term Debt	20.78	98.88	64.52	45.67	-
Current Portion of Leases	11.79	16.98	13.38	14.38	9.97
Current Income Taxes Payable	3.7	1.54	0.85	5.15	5.72
Current Unearned Revenue	260.34	202.26	180.19	382.71	466.69
Other Current Liabilities	106.02	145.89	143.29	131.17	90.02
Total Current Liabilities	1,188	1,189	1,178	1,360	1,136
Long-Term Debt	63.23	25.14	110.85	40.07	54.27
Long-Term Leases	10.26	31.2	52.14	62.87	34.89
Long-Term Unearned Revenue	0.47	0.14	0.34	0.54	0.75
Long-Term Deferred Tax Liabilities	41.89	40.18	37.84	37.74	30.25
Other Long-Term Liabilities	-	4.83	4.64	4.19	-
Total Liabilities	1,304	1,290	1,383	1,505	1,256
Common Stock	4.07	4.07	4.07	4.07	4.07
Additional Paid-In Capital	-	339.55	339.55	339.55	344.16
Retained Earnings	366.59	401.37	385.29	498.77	411.31
Comprehensive Income & Other	451.89	46.41	44.09	54.55	27.05
Total Common Equity	822.55	791.41	773.01	896.94	786.58
Minority Interest	1.54	2.06	2.46	-13.36	1.84
Shareholders' Equity	824.09	793.47	775.47	883.58	788.42
Total Liabilities & Equity	2,128	2,084	2,159	2,389	2,045
Total Debt	343.68	401.95	496.2	336.55	155.22
Net Cash (Debt)	-116.28	-234.15	-322.43	-188.42	64.52
Net Cash Growth	-	-	-	-	-36.53%
Net Cash Per Share	-0.23	-0.46	-0.63	-0.37	0.13
Filing Date Shares Outstanding	512.58	512.58	512.58	512.58	512.58
Total Common Shares Outstanding	512.58	512.58	512.58	512.58	512.58
Working Capital	425.64	363.08	396.13	441.24	527.05
Book Value Per Share	1.60	1.54	1.51	1.75	1.53
Tangible Book Value	782.15	749.11	730.54	841.08	765.47
Tangible Book Value Per Share	1.53	1.46	1.43	1.64	1.49
Buildings	-	267.41	249.41	17.37	16.62
Machinery	-	84.88	92.57	80.6	75.1
Construction In Progress	-	5.03	4.51	214.04	135.56
Order Backlog	-	1,082	1,014	1,442	1,593

Source: S&P Global Market Intelligence. Standard template. Financial Sources.